In metastatic 66cl-4 breast cancer cells we found that VEGF levels increased in CH cells (100%) compared to CN cells (26%) as expected, but VEGF levels remained low in MN (37%) and MH (18%) cells (Fig 2). This evidence concerns the gene VEGFA and breast carcinoma.